XML 95 R81.htm IDEA: XBRL DOCUMENT
v3.24.0.1

STOCKHOLDERS' EQUITY - Stock Issued by Acquisition (Details) - USD ($) |  |  |  | 1 Months Ended |
--- | --- | --- | --- | --- | ---
Apr. 14, 2021 | Jan. 11, 2021 | Jan. 05, 2021 | May 31, 2022 | Dec. 31, 2021 | Apr. 30, 2021 | Jan. 31, 2021 | May 01, 2022
PreventionGenetics |  |  |  |  |  |  |  |
Changes in Accumulated Other Comprehensive Income (Loss) |  |  |  |  |  |  |  |
Equity issued to acquire business (in shares) |  |  |  |  | 1,070,410 |  |  |
Fair value of stock issued in acquisition |  |  |  |  | $ 84,252,000 |  |  |
Ashion Analytics |  |  |  |  |  |  |  |
Changes in Accumulated Other Comprehensive Income (Loss) |  |  |  |  |  |  |  |
Equity issued to acquire business (in shares) | 125,444 |  |  |  |  | 125,444 |  |
Fair value of stock issued in acquisition |  |  |  |  |  | $ 16,224,000 |  |
Thrive |  |  |  |  |  |  |  |
Changes in Accumulated Other Comprehensive Income (Loss) |  |  |  |  |  |  |  |
Equity issued to acquire business (in shares) |  |  | 9,323,266 |  |  |  | 9,323,266 |
Fair value of stock issued in acquisition |  |  | $ 1,190,000,000 |  |  |  | $ 1,191,420,000 |
TARDIS Technology |  |  |  |  |  |  |  |
Changes in Accumulated Other Comprehensive Income (Loss) |  |  |  |  |  |  |  |
Equity issued to acquire business (in shares) |  | 191,335 |  |  |  |  |  |
Fair value of stock issued in acquisition |  | $ 27,263,000 |  |  |  |  |  |
OmicEra |  |  |  |  |  |  |  |
Changes in Accumulated Other Comprehensive Income (Loss) |  |  |  |  |  |  |  |
Equity issued to acquire business (in shares) |  |  |  | 265,186 |  |  |  |
Fair value of stock issued in acquisition |  |  |  |  |  |  |  | $ 14,792,000

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=exas_PreventionGeneticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=exas_TARDISTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=exas_OmicEraMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |